The 2026 Nobel Prize in Physiology or Medicine has been awarded to three researchers whose work revealed how individual nerve cells can be turned on or off, a discovery that helped launch one of the most influential techniques in modern neuroscience.
The prize committee announced Monday in Stockholm that Karl Deisseroth, Peter Hegemann and Georg Nagel will share the award for their investigations into light-gated ion channels and the field known as optogenetics. The three scientists are affiliated with universities in Germany and the United States.
Deisseroth, 54, is a professor at Stanford University, where he holds appointments in the departments of bioengineering and psychiatry. Hegemann, 71, and Nagel, 73, are both based at German institutions. Together, their complementary research programs laid the foundation for a technology that allows scientists to control the activity of precise sets of neurons using pulses of light.
At its core, the work addresses a fundamental question in neuroscience: how does the brain manage to activate or silence individual cells within the dense, tangled networks that govern thought, movement, memory and emotion? The laureates' research helped answer that question by identifying and harnessing naturally occurring proteins that act as light-sensitive gateways in cell membranes.
These proteins, known as light-gated ion channels, are found in certain microorganisms. When struck by light of a specific wavelength, they open or close, allowing electrically charged particles to flow into or out of a cell. That flow of ions is precisely what generates the electrical signals neurons use to communicate.
By transferring the genes for these proteins into nerve cells, researchers found they could make those cells respond to light as well. Shine a beam on a targeted neuron, and it fires. Switch the light off, and it falls silent. The technique gave scientists an unprecedented degree of control over brain circuits that had previously been accessible only through electrodes or drugs that affected broad regions of tissue.
The approach became widely known as optogenetics, a method that combines optics and genetics. Its appeal lies in its precision. Rather than influencing large swaths of the brain indiscriminately, optogenetics allows researchers to activate or inhibit specific populations of neurons, often in awake, behaving animals, and then observe how behavior changes.
That capability has transformed laboratories around the world. Scientists have used the technique to probe the neural circuits underlying sleep, hunger, fear, reward and addiction. It has also offered clues about what goes wrong in conditions such as Parkinson's disease, depression, epilepsy and chronic pain, where the normal balance of excitation and inhibition in the brain is disrupted.
The Nobel committee praised the laureates for opening a window into brain function that had long been closed. Their research, the committee noted, made it possible to switch nerve cell activity on or off with light, providing a tool that has become standard in neuroscience research.
The recognition also highlights the collaborative nature of scientific discovery. The prize is shared among three researchers whose work built on one another over years. Hegemann and Nagel, working in Germany, helped identify and characterize the light-sensitive proteins that made the technique possible. Deisseroth, working in the United States, demonstrated how those molecules could be deployed in mammalian neurons and turned into a practical research method.
Each year, the Nobel Assembly at Karolinska Institutet in Stockholm selects the winner of the medicine prize, the first of the Nobel awards to be announced. The prize carries a monetary award and worldwide recognition, and it often brings sudden attention to fields of research that may have been quietly developing for decades.
The announcement places optogenetics squarely in the spotlight. Over the past two decades, the field has grown from a promising experimental idea into an essential part of the neuroscience toolkit. Thousands of laboratories now use light-based methods to map the connections between neurons and to test what happens when specific circuits are disrupted or restored.
Beyond basic science, the technique has inspired hopes for new therapies. Researchers are exploring whether light can be used to stimulate or calm malfunctioning brain circuits in patients, an approach sometimes called optogenetic therapy. While clinical applications remain in early stages, the underlying science has already reshaped how scientists think about the relationship between brain activity and behavior.
For Deisseroth, the award adds to a long list of honors, including the Japan Prize in the life sciences, which he received in 2023. That recognition, like the Nobel, reflected the far-reaching influence of his work on brain research and psychiatric understanding.
The 2026 medicine prize also underscores a broader trend in modern science: the most powerful discoveries often emerge at the intersection of disciplines. Optogenetics draws on microbiology, genetics, optics and electrical engineering, showing how insights from one field can unlock entirely new possibilities in another.
The laureates' achievement is not a single experiment but a body of work spanning years of painstaking research. It gave neuroscientists a tool they had long dreamed of, the ability to reach into the brain and control its most basic units with nothing more than a beam of light. That tool is now helping to answer questions about how the brain works and what happens when it does not.
(0)